A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes.
Ando H, Yoshinaga T, Yamamoto W, Asakura K, Uda T, Taniguchi T, Ojima A, Shinkyo R, Kikuchi K, Osada T, Hayashi S, Kasai C, Miyamoto N, Tashibu H, Yamazaki D, Sugiyama A, Kanda Y, Sawada K, Sekino Y.
Ando H, et al. Among authors: ojima a.
J Pharmacol Toxicol Methods. 2017 Mar-Apr;84:111-127. doi: 10.1016/j.vascn.2016.12.003. Epub 2016 Dec 10.
J Pharmacol Toxicol Methods. 2017.
PMID: 27956204
Free article.